2m 2m 2m 2m 2m 2m 2m
REPLIMUNE GRP (REPL)
NASDAQ
$9.90+$1.03 (+11.60%)
Price as of Jun 03, 2026 7:17 PM EDT- $717.6MMarket Cap
- -7.89%1-Year Change
- BiotechnologyIndustry
REPLIMUNE GRP (REPL)
$9.90+$1.03 (+11.60%)
REPL | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $8.87 | ||
Change | -$0.13 (-1.44%) | ||
Open | $8.90 | ||
High | $9.49 | ||
Low | $8.51 | ||
Previous Close | $9.00 | ||
Volume | 6,207,353 | ||
30-Day Average Volume | 8,995,685 | ||
1-Week Change | 92.83% | ||
1-Month Change | 254.80% | ||
1-Year Change | -7.89% | ||
3-Year Change | -53.29% | ||
5-Year Change | -75.53% | ||
Fundamentals | |||
Shares Outstanding | 82.6M | ||
Total Assets | $333.6M | ||
Market Cap | $717.6M | ||
Enterprise Value | $642.2M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$70.9M | ||
Free Cash Flow | -$66.1M | ||
EBIT | -$69.8M | ||
EBITDA | -$68.9M | ||
Net Working Capital | $230.3M | ||
EPS | -$0.77 | ||
Enterprise Value/EBITDA | -9 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 3 | ||
P/E | -11 | ||
PEG | -1 | ||
Price/Free Cash Flow | -11 | ||
Price/Operating Cash Flow | -11 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 15 : 1 | ||
Last Split Date | 12/01/2010 | ||